Figure 1.
Frequency of mutations in patients with CML by TKI therapy response. Summary of mutation frequency at diagnosis (A) and follow-up sample (B). The mutations were classified according to their biological pathway.
Frequency of mutations in patients with CML by TKI therapy response. Summary of mutation frequency at diagnosis (A) and follow-up sample (B). The mutations were classified according to their biological pathway.
